Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. SI-BONE, Inc.
  6. News
  7. Summary
    SIBN   US8257041090

SI-BONE, INC.

(SIBN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Si Bone : says Centene Establishes Positive Coverage Policy for its iFuse Implant System

07/14/2021 | 08:11am EDT


ę MT Newswires 2021
All news about SI-BONE, INC.
08/23SI BONE : to Participate in Upcoming Conferences
AQ
08/13SI-BONE, INC. : Entry into a Material Definitive Agreement, Termination of a Material Defi..
AQ
08/13Si-Bone, Inc. Enters into A Loan and Security Agreement with Silicon Valley Bank., A Ca..
CI
08/04SI BONE : Management's Discussion and Analysis of Financial Condition and Results of Opera..
AQ
08/03SI BONE : Reports Second Quarter 2021 Financial Results and Announces Exclusive Coverage f..
PU
08/03SI BONE : Needham Adjusts SI-Bone's Price Target to $37 From $42; Buy Rating Kept
MT
08/02SI-BONE : Q2 Earnings Snapshot
AQ
08/02SI-BONE, INC. : Results of Operations and Financial Condition, Financial Statements and Ex..
AQ
08/02Si-Bone, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
08/02SI BONE : Earnings Flash (SIBN) SI-BONE Posts Q2 Revenue $20.2M, vs. Street Est of $21.7M
MT
More news
Analyst Recommendations on SI-BONE, INC.
More recommendations
Financials (USD)
Sales 2021 93,1 M - -
Net income 2021 -52,2 M - -
Net cash 2021 104 M - -
P/E ratio 2021 -14,6x
Yield 2021 -
Capitalization 775 M 775 M -
EV / Sales 2021 7,20x
EV / Sales 2022 5,85x
Nbr of Employees 295
Free-Float 98,1%
Chart SI-BONE, INC.
Duration : Period :
SI-BONE, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SI-BONE, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 23,28 $
Average target price 40,86 $
Spread / Average Target 75,5%
EPS Revisions
Managers and Directors
Laura A. Francis Chief Executive Officer & Director
Anshul Maheshwari Chief Financial & Accounting Officer
Jeffrey W. Dunn Executive Chairman
Scott A. Yerby Chief Technology Officer
W. Carlton Reckling Chief Medical Officer & VP-Medical Affairs
Sector and Competitors
1st jan.Capi. (M$)
SI-BONE, INC.-22.14%775
MASIMO CORPORATION2.62%15 037
NOVOCURE LIMITED-25.82%13 154
GETINGE AB88.60%11 356
PENUMBRA, INC.61.86%10 158
ASAHI INTECC CO., LTD.-13.94%8 131